Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Evaluation of Safety and Performance

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Boston Scientific Corporation Identifier:
First received: June 5, 2012
Last updated: January 14, 2014
Last verified: January 2014